Newsroom

Sorted by: Latest

-

Shareholder Alert: Bernstein Litowitz Berger & Grossmann LLP Announces the Filing of Securities Class Action Lawsuit Against LKQ Corporation

NEW YORK--(BUSINESS WIRE)--Today, prominent investor rights law firm Bernstein Litowitz Berger & Grossmann LLP (“BLB&G”) filed a class action in the U.S. District Court for the Middle District of Tennessee alleging violations of the federal securities laws by LKQ Corporation (“LKQ” or the “Company”) and certain of the Company’s current and former senior executives (collectively, “Defendants”). The action is brought on behalf of all investors who purchased or otherwise acquired LKQ commo...
-

Helix Reports First Quarter 2026 Results

HOUSTON--(BUSINESS WIRE)--Helix Energy Solutions Group, Inc. ("Helix") (NYSE: HLX) reported a net loss of $13.4 million, or $(0.09) per diluted share, for the first quarter 2026 compared to net income of $8.3 million, or $0.06 per diluted share, for the fourth quarter 2025 and net income of $3.1 million, or $0.02 per diluted share, for the first quarter 2025. Net income during the fourth quarter 2025 included a non-cash impairment charge for certain of our oil and gas properties of approximatel...
-

Resumen: Veristat adquirirá la unidad de redacción médica y regulatoria de Certara

SOUTHBOROUGH, Massachusetts--(BUSINESS WIRE)--Veristat (la «Compañía»), una organización de investigación por contrato (CRO) y consultora que ofrece servicios integrales en el ámbito científico e impulsa el avance de terapias complejas desde el desarrollo de fármacos hasta su presentación ante las autoridades regulatorias, acaba de anunciar su intención de adquirir la unidad de redacción médica y regulatoria de Certara. El equipo que se incorporará a Veristat es reconocido por sus servicios de...
-

Riassunto: Veristat acquisisce l'attività di redazione di documenti normativi e medici di Certara

SOUTHBOROUGH, Massachusetts--(BUSINESS WIRE)--Veristat (l'"Azienda"), una CRO e società di consulenza a servizio completo incentrata sulla scienza che promuove terapie complesse durante il ciclo di vita dello sviluppo di farmaci fino all'invio normativo, ha annunciato oggi l'intenzione di acquisire l'attività di redazione di documenti normativi e medici di Certara. Il team che si unirà a Veristat è noto per i suoi servizi di consulenza di altissimo livello e per le competenze approfondite nella...
-

Samenvatting: Veristat neemt Certara’s Regulatory & Medical Writing activiteit over

SOUTHBOROUGH, Mass.--(BUSINESS WIRE)--Veristat (het “Bedrijf”), een full-service CRO die wetenschap voorop stelt en een consultancy die complexe therapieën bevordert tijdens de hele levenscyclus gaande van ontwikkeling van geneesmiddelen tot indiening van de aanvraag voor regelgevende toelating, kondigde vandaag zijn beoogde overname van Certara’s Regulatory & Medical Writing activiteit aan. Het team dat zich bij Veristat zal voegen, staat bekend voor zijn bureaucratische adviesdiensten en...
-

Veristat annonce l’acquisition des activités d’affaires réglementaires et de rédaction médicale de Certara

SOUTHBOROUGH, Massachusetts--(BUSINESS WIRE)--Veristat (la « société »), CRO et société de conseil full-service axée sur la science, qui accompagne le développement de thérapies complexes tout au long du cycle de développement des médicaments jusqu’au dépôt des dossiers réglementaires, a annoncé aujourd’hui son intention d’acquérir les activités d’affaires réglementaires et de rédaction médicale de Certara. L’équipe appelée à rejoindre Veristat est reconnue pour ses services de conseil à forte...
-

Veristat übernimmt den Geschäftsbereich Regulatory and Medical Writing von Certara

SOUTHBOROUGH, Massachusetts--(BUSINESS WIRE)--Veristat (das „Unternehmen“), eine forschungsorientierte Full-Service-CRO und Beratungsfirma, die komplexe Therapien über den gesamten Lebenszyklus der Arzneimittelentwicklung bis hin zum Zulassungsantrag vorantreibt, hat heute seine geplante Übernahme des Geschäftsbereichs Regulatory and Medical Writing von Certara bekannt gegeben. Das Team, das zu Veristat wechseln wird, ist für seine erstklassigen Beratungsleistungen und seine fundierte Expertise...
-

Arbor Day Foundation, Peanuts Worldwide Invited to Light Empire State Building on Earth Day

LINCOLN, Neb.--(BUSINESS WIRE)--The Arbor Day Foundation lit up the Empire State Building in New York City on Wednesday, in celebration of both Earth Day and National Arbor Day. The global tree planting nonprofit was joined by Snoopy, the beloved character from the iconic Peanuts comic strip by Charles M. Schulz. “The Empire State Building always marks the moments that matter. So, by turning it green on Earth Day, we’re sending a message to the world that planting trees is more important than e...
-

Citi Announces Offers to Purchase Three Series of Outstanding Citigroup Inc. Notes

NEW YORK--(BUSINESS WIRE)--Citigroup Global Markets Inc. (“CGMI”), an indirect wholly-owned subsidiary of Citigroup Inc. (“Citigroup”), today announced the commencement of offers to purchase for cash the three series of Citigroup notes set forth in the table below (collectively, the “Notes” and each a “series” of Notes), using a “waterfall” methodology under which CGMI will accept Notes in the order of their respective Acceptance Priority Levels specified in the table below, subject to a $1,250...
-

VERITONE, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Veritone, Inc. (“Veritone” or the “Company”) (NASDAQ:VERI). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On March 26, 2026, Veritone filed an 8-K with the U.S. Securities and Exchange Commission (“SEC”) announ...